Live Breaking News & Updates on Tier Pricing Agreement
Stay updated with breaking news from Tier pricing agreement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PURE Bioscience, Inc. ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2024.